Search results for "From ACP Journal Club"
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes
The review shows that, contrary to specialty recommendations, there is no reason not to use regular human insulins, which are less costly than analogue insulins, said an ACP Journal Club commentary. ... The following commentary by Mayer B. Davidson, MD,
May 2019
In type 2 diabetes with periodontitis, intensive periodontitis treatment improved glycemic control at 1 year
referrals, the ACP Journal Club commentary said. ... The following commentary by Zubin Punthakee, MD, was published in the ACP Journal Club section of the April 16 Annals of Internal Medicine.
May 2019
Review: Evidence is inconclusive on metabolic surgery vs. medical treatment for microvascular complications in T2DM
The following commentary by Reema Shah, MD, was published in the ACP Journal Club section of the July 17 Annals of Internal Medicine. ... All articles from the August 10, 2018, ACP Diabetes Monthly Newsletter.
August 2018
In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function
ACP Journal Club commentary. ... Herrington, MD, Doreen Zhu, MBChB, and Richard Haynes, DM, was published in the ACP Journal Club section of the Feb.
March 2019
In high-risk pregnant women, an individualized lifestyle intervention reduced gestational diabetes mellitus
The following commentary by Lorraine Lipscombe, MD, MSc, was published in the ACP Journal Club section of the Dec. ... All articles from the January 8, 2016, ACP Diabetes Monthly Newsletter.
January 2016
From ACP Journal Club
Three different industry-funded studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recently analyzed in ACP Journal Club. ... The following commentary by Lorraine L. Lipscombe, MD, MSc, was published with all three study recaps in the
October 2019
From ACP Journal Club
An ACP Journal Club commentary recommends advising patients with type 2 diabetes who don't smoke and who take metformin to also consider increasing their soluble fiber intake by more than ... The review was published in the January Diabetes Care. The
June 2019
Risk scores overestimated risk for CVD in newly diagnosed type 2 diabetes
Available risk scores are in need of recalibration but still serve as useful decision-making tools, according to an ACP Journal Club commentary. ... The study was published in the September Diabetes Care. The following commentary by Michael Tanner, MD,
December 2018
In diabetes with no CVD, aspirin reduced serious vascular events but increased major bleeding at 7.4 years
according to an ACP Journal Club commentary. ... The following commentary by Gaetano Santulli, MD, was published in the ACP Journal Club section of the Dec.
January 2019
Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death
for preventing any complications is warranted, ACP Journal Club authors wrote. ... Singh, MBBS, MBA, was published in the ACP Journal Club section of the Oct.
November 2017